Stock Screener
Stock Research
Delisted Stocks
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

Champions Oncology EBITDA 2010-2024 | CSBR

Champions Oncology ebitda from 2010 to 2024. Ebitda can be defined as earnings before interest, taxes, depreciation and amortization.
  
Champions Oncology Annual EBITDA
(Millions of US $)
2023 $-3
2022 $2
2021 $2
2020 $-1
2019 $1
2018 $-1
2017 $-7
2016 $-10
2015 $-13
2014 $-6
2013 $-6
2012 $-9
2011 $-5
2010 $-3
2009 $-2
Champions Oncology Quarterly EBITDA
(Millions of US $)
2024-01-31 $-2
2023-10-31 $-1
2023-07-31 $-2
2023-04-30 $-2
2023-01-31 $-2
2022-10-31 $1
2022-07-31 $0
2022-04-30 $0
2022-01-31 $1
2021-10-31 $1
2021-07-31 $0
2021-04-30 $-0
2021-01-31 $1
2020-10-31 $0
2020-07-31 $0
2020-04-30 $-1
2020-01-31 $1
2019-10-31 $0
2019-07-31 $-0
2019-04-30 $0
2019-01-31 $-0
2018-10-31 $0
2018-07-31 $1
2018-04-30 $-0
2018-01-31 $0
2017-10-31 $0
2017-07-31 $-1
2017-04-30 $-2
2017-01-31 $-1
2016-10-31 $-0
2016-07-31 $-2
2016-04-30 $-3
2016-01-31 $-2
2015-10-31 $-2
2015-07-31 $-3
2015-04-30 $-2
2015-01-31 $-3
2014-10-31 $-4
2014-07-31 $-4
2014-04-30 $-2
2014-01-31 $-1
2013-10-31 $-2
2013-07-31 $-1
2013-04-30 $-2
2013-01-31 $-1
2012-10-31 $-2
2012-07-31 $-2
2012-04-30 $-3
2012-01-31 $-2
2011-10-31 $-2
2011-07-31 $-2
2011-04-30 $-3
2011-01-31 $-1
2010-10-31 $-1
2010-07-31 $-1
2010-04-30 $-1
2010-01-31 $-1
2009-10-31 $-1
2009-07-31 $-1
2009-04-30 $-1
2009-01-31 $-1
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $0.069B $0.054B
Champions Oncology, Inc., formerly known as Champions Biotechnology, Inc., engages in the development of advanced technology solutions to personalize the development and use of oncology drugs. The Company's Tumorgraft Technology Platform is a novel approach to personalizing cancer care based upon the implantation of human tumors in immune deficient mice followed by propagation of the resulting engraftments. This technology can evaluate tumor sensitivity/resistance to various single, combination standard and novel chemotherapy agents. Champions Oncology, Inc. is based in Baltimore, Maryland.
Stock Name Country Market Cap PE Ratio
Zoetis (ZTS) United States $80.518B 32.74
Chugai Pharmaceutical (CHGCY) Japan $59.516B 26.60
Takeda Pharmaceutical (TAK) Japan $40.858B 8.28
Merck (MKGAF) Germany $21.654B 21.00
Astellas Pharma (ALPMY) Japan $17.952B 28.34
Sandoz Group AG (SDZNY) Switzerland $15.762B 0.00
United Therapeutics (UTHR) United States $14.058B 14.98
Neurocrine Biosciences (NBIX) United States $13.517B 37.00
Shionogi (SGIOY) Japan $11.482B 9.98
Catalent (CTLT) United States $10.209B 0.00
Cerevel Therapeutics Holdings (CERE) United States $7.379B 0.00
Ionis Pharmaceuticals (IONS) United States $6.894B 0.00
Jazz Pharmaceuticals (JAZZ) Ireland $6.754B 7.42
Revolution Medicines (RVMD) United States $6.357B 0.00
Madrigal Pharmaceuticals (MDGL) United States $6.088B 0.00
Orion OYJ (ORINY) Finland $6.014B 25.36
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $5.561B 0.00
Summit Therapeutics (SMMT) United States $5.525B 0.00
Crinetics Pharmaceuticals (CRNX) United States $3.428B 0.00
Corcept Therapeutics (CORT) United States $3.338B 30.25
Arrowhead Pharmaceuticals (ARWR) United States $3.191B 0.00
Dyne Therapeutics (DYN) United States $3.095B 0.00
PTC Therapeutics (PTCT) United States $2.658B 0.00
Indivior (INDV) United States $2.258B 10.71
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $1.982B 11.26
Recursion Pharmaceuticals (RXRX) United States $1.800B 0.00
Catalyst Pharmaceuticals (CPRX) United States $1.776B 17.29
NewAmsterdam Pharma (NAMS) Netherlands $1.758B 0.00
Evotec AG (EVO) Germany $1.619B 0.00
Ardelyx (ARDX) United States $1.513B 0.00
Soleno Therapeutics (SLNO) United States $1.395B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $1.375B 0.00
Pacira BioSciences (PCRX) United States $1.299B 12.35
BioCryst Pharmaceuticals (BCRX) United States $1.261B 0.00
Xencor (XNCR) United States $1.184B 0.00
Calliditas Therapeutics AB (CALT) Sweden $1.148B 0.00
Enliven Therapeutics (ELVN) United States $1.103B 0.00
4D Molecular Therapeutics (FDMT) United States $1.082B 0.00
Collegium Pharmaceutical (COLL) United States $1.061B 6.35
Ocular Therapeutix (OCUL) United States $1.047B 0.00
Ironwood Pharmaceuticals (IRWD) United States $0.970B 15.12
Cassava Sciences (SAVA) United States $0.909B 0.00
Centessa Pharmaceuticals (CNTA) United Kingdom $0.902B 0.00
Cronos Group (CRON) Canada $0.895B 0.00
USANA Health Sciences (USNA) United States $0.867B 14.18
Relay Therapeutics (RLAY) United States $0.836B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $0.802B 0.00
ARS Pharmaceuticals (SPRY) United States $0.780B 0.00
Harrow (HROW) United States $0.743B 0.00
Sage Therapeutics (SAGE) United States $0.643B 0.00
Exscientia (EXAI) United Kingdom $0.631B 0.00
Silence Therapeutics (SLN) United Kingdom $0.569B 0.00
ProKidney (PROK) United States $0.555B 0.00
Savara (SVRA) United States $0.527B 0.00
Siga Technologies (SIGA) United States $0.523B 6.69
Heron Therapeutics (HRTX) United States $0.514B 0.00
KalVista Pharmaceuticals (KALV) United States $0.508B 0.00
Lexeo Therapeutics (LXEO) United States $0.490B 0.00
Larimar Therapeutics (LRMR) United States $0.469B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.469B 0.00
Bioventus (BVS) United States $0.453B 17.33
Altimmune (ALT) United States $0.453B 0.00
OmniAb (OABI) United States $0.443B 0.00
Esperion Therapeutics (ESPR) United States $0.438B 0.00
Theravance Biopharma (TBPH) Cayman Islands $0.405B 0.00
Verve Therapeutics (VERV) United States $0.400B 0.00
Lyell Immunopharma (LYEL) United States $0.352B 0.00
Organogenesis (ORGO) United States $0.350B 66.00
Tourmaline Bio (TRML) United States $0.339B 0.00
Xeris Biopharma Holdings (XERS) United States $0.335B 0.00
Korro Bio (KRRO) United States $0.310B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.306B 0.00
Nature's Sunshine Products (NATR) United States $0.282B 17.89
Enanta Pharmaceuticals (ENTA) United States $0.268B 0.00
Black Diamond Therapeutics (BDTX) United States $0.264B 0.00
Nanobiotix S.A (NBTX) France $0.264B 0.00
Foghorn Therapeutics (FHTX) United States $0.244B 0.00
Aquestive Therapeutics (AQST) United States $0.236B 0.00
ESSA Pharma (EPIX) Canada $0.230B 0.00
Eliem Therapeutics (ELYM) United States $0.224B 0.00
Profound Medical (PROF) Canada $0.217B 0.00
Century Therapeutics (IPSC) United States $0.214B 0.00
Elite Pharmaceuticals (ELTP) United States $0.214B 20.00
Fractyl Health (GUTS) United States $0.212B 0.00
Nektar Therapeutics (NKTR) United States $0.210B 0.00
Akebia Therapeutics (AKBA) United States $0.207B 0.00
Avita Medical (RCEL) United States $0.205B 0.00
Prelude Therapeutics (PRLD) United States $0.203B 0.00
Aldeyra Therapeutics (ALDX) United States $0.202B 0.00
Zevra Therapeutics (ZVRA) United States $0.201B 0.00
Innate Pharma SA (IPHYF) France $0.200B 0.00
Pyxis Oncology (PYXS) United States $0.189B 0.00
Acrivon Therapeutics (ACRV) United States $0.178B 0.00
Incannex Healthcare (IXHL) Australia $0.169B 0.00
Adherex Technologies (FENC) United States $0.168B 205.00
Rigel Pharmaceuticals (RIGL) United States $0.167B 0.00
Achieve Life Sciences (ACHV) Canada $0.159B 0.00
Context Therapeutics (CNTX) United States $0.151B 0.00
CytoDyn (CYDY) United States $0.148B 0.00
Metagenomi (MGX) United States $0.141B 0.00
MediWound (MDWD) Israel $0.138B 0.00
Cardiol Therapeutics (CRDL) Canada $0.138B 0.00
Galectin Therapeutics (GALT) United States $0.137B 0.00
Regulus Therapeutics (RGLS) United States $0.133B 0.00
Amylyx Pharmaceuticals (AMLX) United States $0.131B 8.77
Telomir Pharmaceuticals (TELO) United States $0.127B 0.00
Assertio Holdings (ASRT) United States $0.125B 5.70
OptiNose (OPTN) United States $0.122B 0.00
Karyopharm Therapeutics (KPTI) United States $0.121B 0.00
VAXART, INC (VXRT) United States $0.118B 0.00
Citius Pharmaceuticals (CTXR) United States $0.115B 0.00
Journey Medical (DERM) United States $0.103B 0.00
FibroGen (FGEN) United States $0.102B 0.00
Relmada Therapeutics (RLMD) United States $0.090B 0.00
AlloVir (ALVR) United States $0.090B 0.00
ARYA Sciences Acquisition Corp IV (ARYD) United States $0.086B 0.00
PMV Pharmaceuticals (PMVP) United States $0.085B 0.00
ProPhase Labs (PRPH) United States $0.081B 0.00
Aclaris Therapeutics (ACRS) United States $0.079B 0.00
Arch Biopartners (ACHFF) Canada $0.078B 0.00
SCYNEXIS (SCYX) United States $0.077B 1.08
Conduit Pharmaceuticals (CDT) United States $0.075B 0.00
Vivani Medical (VANI) United States $0.070B 0.00
Marinus Pharmaceuticals (MRNS) United States $0.068B 0.00
CASI Pharmaceuticals (CASI) China $0.066B 0.00
Nutriband (NTRB) United States $0.059B 0.00
Reneo Pharmaceuticals (RPHM) United States $0.054B 0.00
Carisma Therapeutics (CARM) United States $0.053B 0.00
Mural Oncology (MURA) Ireland $0.052B 0.00
Tempest Therapeutics (TPST) United States $0.048B 0.00
BioLineRx (BLRX) Israel $0.046B 0.00
Inotiv (NOTV) United States $0.045B 0.00
Protara Therapeutics (TARA) United States $0.045B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.043B 0.00
DURECT (DRRX) United States $0.042B 0.00
Lipocine (LPCN) United States $0.041B 0.00
ElectroCore (ECOR) United States $0.039B 0.00
Natural Alternatives (NAII) United States $0.038B 0.00
Reviva Pharmaceuticals Holdings (RVPH) United States $0.036B 0.00
Rafael Holdings (RFL) United States $0.035B 0.00
Surrozen (SRZN) United States $0.032B 0.00
Enlivex Therapeutics (ENLV) Israel $0.031B 0.00
VYNE Therapeutics (VYNE) United States $0.029B 0.00
NRx Pharmaceuticals (NRXP) United States $0.028B 0.00
BioVie (BIVI) United States $0.027B 0.00
Aptorum Group (APM) United Kingdom $0.024B 0.00
Oncternal Therapeutics (ONCT) United States $0.023B 0.00
Viracta Therapeutics (VIRX) United States $0.023B 0.00
Gain Therapeutics (GANX) United States $0.023B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.022B 0.00
Minerva Neurosciences (NERV) United States $0.021B 0.00
GlycoMimetics (GLYC) United States $0.020B 0.00
PolyPid (PYPD) Israel $0.020B 0.00
TherapeuticsMD (TXMD) United States $0.020B 0.00
Iterum Therapeutics (ITRM) Ireland $0.020B 0.00
JanOne (JAN) United States $0.020B 0.00
MEI Pharma (MEIP) United States $0.020B 0.75
Indaptus Therapeutics (INDP) United States $0.019B 0.00
SHINECO (SISI) China $0.019B 0.00
Jaguar Animal Health (JAGX) United States $0.018B 0.00
Nuvilex (PMCB) United States $0.018B 0.00
Lyra Therapeutics (LYRA) United States $0.016B 0.00
Talphera (TLPH) United States $0.015B 0.00
Unicycive Therapeutics (UNCY) United States $0.015B 0.00
Avalo Therapeutics (AVTX) United States $0.014B 0.00
Mannatech (MTEX) United States $0.013B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.012B 0.00
Kiora Pharmaceuticals (KPRX) United States $0.012B 0.00
Alaunos Therapeutics (TCRT) United States $0.012B 0.00
Cosmos Health (COSM) Greece $0.012B 0.00
Traws Pharma (TRAW) United States $0.011B 0.00
Dominari Holdings (DOMH) United States $0.011B 0.00
Redhill Biopharma (RDHL) Israel $0.011B 0.00
Inhibikase Therapeutics (IKT) United States $0.010B 0.00
Universe Pharmaceuticals INC (UPC) China $0.009B 0.00
Addex Therapeutics (ADXN) Switzerland $0.009B 0.00
Plus Therapeutics (PSTV) United States $0.008B 0.00
Mangoceuticals (MGRX) United States $0.008B 0.00
Vivos Therapeutics (VVOS) United States $0.008B 0.00
Biomerica (BMRA) United States $0.008B 0.00
Molecular Templates (MTEM) United States $0.007B 0.00
TransCode Therapeutics (RNAZ) United States $0.007B 0.00
Xenetic Biosciences (XBIO) United States $0.006B 0.00
Shuttle Pharmaceuticals Holdings (SHPH) United States $0.006B 0.00
Heatwurx (PCSA) United States $0.006B 0.00
Ainos (AIMD) United States $0.006B 0.00
CERo Therapeutics Holdings (CERO) United States $0.005B 0.00
MyMD Pharmaceuticals (MYMD) United States $0.004B 0.00
Bio-Path Holdings (BPTH) United States $0.004B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.004B 0.00
XORTX Therapeutics (XRTX) Canada $0.004B 0.00
Avenue Therapeutics (ATXI) United States $0.003B 0.00
60 Degrees Pharmaceuticals (SXTP) United States $0.003B 0.00
Phio Pharmaceuticals (PHIO) United States $0.003B 0.00
Petros Pharmaceuticals (PTPI) United States $0.003B 0.00
Quoin Pharmaceuticals (QNRX) United States $0.002B 0.00
Clearmind Medicine (CMND) Canada $0.002B 0.00
InMed Pharmaceuticals (INM) Canada $0.002B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.002B 0.00
Altamira Therapeutics (CYTO) Bermuda $0.002B 0.00
Salarius Pharmaceuticals (SLRX) United States $0.001B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.001B 0.00
Qualigen Therapeutics (QLGN) United States $0.001B 0.00
PainReform (PRFX) Israel $0.001B 0.00
SciSparc (SPRC) Israel $0.001B 0.00
China SXT Pharmaceuticals (SXTC) China $0.001B 0.00
Aditxt (ADTX) United States $0.000B 0.00
Qilian Holding Group (QLI) China $0.000B 0.00
Grifols, S.A (GRFS) Spain $0.000B 0.00
4D Pharma (LBPS) United Kingdom $0.000B 0.00
NLS Pharmaceutics (NLSP) Switzerland $0.000B 0.00
Procaps Group, S.A (PROC) Luxembourg $0.000B 4.83
Patheon (PTHN) Netherlands $0.000B 0.00
RVL Pharmaceuticals (RVLP) United States $0.000B 0.00
Stevanato Group S.p.A (STVN) Italy $0.000B 31.75